Ethiopia

Gap Funding for Impact

Country Context

Ethiopia carries one of the largest NTD burdens in sub-Saharan Africa, making it a high priority country for the END Fund and the NTD community as a whole. In order to most effectively plan and implement treatment campaigns a national mapping effort, funded by the Department for International Development (DFID), was undertaken to collect disease prevalence data and determine the distribution of the most prevalent NTDs. The Centre for Neglected Tropical Diseases at the Liverpool School of Tropical Medicine (CNTD) completed mapping of lymphatic filariasis (LF) and the Schistosomiasis Control Initiative (SCI) completed mapping of schistosomiasis and intestinal worms. Mapping results were then analyzed to begin planning and implementing targeted treatment efforts.

END Fund Investment

The END Fund partnered with CNTD, SCI and the FMoH to support various components of Ethiopia’s NTD control efforts. This strategic approach provides the END Fund the opportunity to fully engage in Ethiopia’s NTD elimination strategy.

Program to Date

Through a partnership with CNTD, the END Fund supported LF mapping in 660 woredas where 160 health workers were trained on NTD mapping techniques. A total of 132,000 individuals were tested for LF and all positive cases were referred to health facilities for treatment. Results identified 83 woredas as endemic for LF. The maps created as a result of this program are important tools used for planning LF treatment interventions.

Currently, the END Fund is engaged in two NTD treatment efforts in Ethiopia. In partnership with the FMoH, the END Fund is supporting a deworming campaign aimed at reaching school-age children in three high endemic regions with treatment for intestinal worms. In partnership with SCI, the END Fund is leveraging a DFID investment in national treatment for schistosomiasis and intestinal worms in areas where they are co-endemic.